0001140361-14-039025.txt : 20141024
0001140361-14-039025.hdr.sgml : 20141024
20141024165652
ACCESSION NUMBER: 0001140361-14-039025
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141022
FILED AS OF DATE: 20141024
DATE AS OF CHANGE: 20141024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Raptor Pharmaceutical Corp
CENTRAL INDEX KEY: 0001070698
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 860883978
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7 HAMILTON LANDING
STREET 2: SUITE 100
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 415-408-6200
MAIL ADDRESS:
STREET 1: 7 HAMILTON LANDING
STREET 2: SUITE 100
CITY: NOVATO
STATE: CA
ZIP: 94949
FORMER COMPANY:
FORMER CONFORMED NAME: Raptor Pharmaceutical Corp.
DATE OF NAME CHANGE: 20090929
FORMER COMPANY:
FORMER CONFORMED NAME: TorreyPines Therapeutics, Inc.
DATE OF NAME CHANGE: 20061003
FORMER COMPANY:
FORMER CONFORMED NAME: AXONYX INC
DATE OF NAME CHANGE: 19990303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STARR CHRISTOPHER M
CENTRAL INDEX KEY: 0001235470
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-25571
FILM NUMBER: 141172931
MAIL ADDRESS:
STREET 1: C/O RAPTOR PHARMACEUTICAL INC.
STREET 2: 9 COMMERCIAL BLVD., SUITE 200
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc1.xml
FORM 4
X0306
4
2014-10-22
0
0001070698
Raptor Pharmaceutical Corp
RPTP
0001235470
STARR CHRISTOPHER M
C/O RAPTOR PHARMACEUTICAL CORP.
7 HAMILTON LANDING, SUITE 100
NOVATO
CA
94949
1
1
0
0
Chief Executive Officer
Common Stock
2014-10-22
4
M
0
30000
2.97
A
729370
D
Common Stock
2014-10-22
4
S
0
30000
10.2475
D
699370
D
Stock options (right to buy)
2.97
2014-10-22
4
M
0
30000
0
D
2020-10-11
Common Stock
30000
0
D
Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 20, 2014.
This transaction was executed in multiple trades at prices ranging from $10.08 to 10.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Fully vested and exercisable.
/s/ Mark Jones, Raptor Pharmaceutical Corp., Attorney-in-Fact
2014-10-24